PCSK9 inhibitors and diabetes: Translational biology to clinical practice

Robert J. Chilton; Rene Oliveros; Kelly M. Gallegos; Son Pham

doi:10.1111/dom.13600

PCSK9 inhibitors and diabetes: Translational biology to clinical practice

Robert J. Chilton
, Rene Oliveros
, Kelly M. Gallegos
, Son Pham

Division of Cardiology

Producción científica: Comment/debate › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	451-453
Número de páginas	3
Publicación	Diabetes, Obesity and Metabolism
Volumen	21
N.º	3
DOI	https://doi.org/10.1111/dom.13600
Estado	Published - mar 2019

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

Acceder al documento

10.1111/dom.13600

Otros archivos y enlaces

Citar esto

@article{42fa834df69b4cc19ece78339c26458c,

title = "PCSK9 inhibitors and diabetes: Translational biology to clinical practice",

author = "Chilton, \{Robert J.\} and Rene Oliveros and Gallegos, \{Kelly M.\} and Son Pham",

year = "2019",

month = mar,

doi = "10.1111/dom.13600",

language = "English (US)",

volume = "21",

pages = "451--453",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - PCSK9 inhibitors and diabetes

T2 - Translational biology to clinical practice

AU - Chilton, Robert J.

AU - Oliveros, Rene

AU - Gallegos, Kelly M.

AU - Pham, Son

PY - 2019/3

Y1 - 2019/3

UR - https://www.scopus.com/pages/publications/85060220384

UR - https://www.scopus.com/pages/publications/85060220384#tab=citedBy

U2 - 10.1111/dom.13600

DO - 10.1111/dom.13600

M3 - Comment/debate

C2 - 30520245

AN - SCOPUS:85060220384

SN - 1462-8902

VL - 21

SP - 451

EP - 453

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 3

ER -